Ronald Melki
Ronald Melki publishes mostly in Molecular Biology, Neurology and Physiology, on topics such as Parkinson's Disease Mechanisms and Treatments, Alzheimer's disease research and treatments and Prion Diseases and Protein Misfolding.
- World rank
- #52,926 of 7,710,434 ranked researchers
- Rank in France
- #5,514 of 324,115
- Works
- 289
- Citations
- 21k
- Citations per work
- 73.3
What does Ronald Melki research?
Ronald Melki's work is mostly in Medicine (34%), Biochemistry, Genetics and Molecular Biology (30%), Neuroscience (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences13647.1%
- Biochemistry, Genetics and Molecular Biology8629.8%
- Neuroscience5017.3%
- Health Sciences9834.0%
- Medicine9834.0%
- Everything else5518.9%
- 1Molecular Biology23% of their works
- 2Neurology22% of their works
- 3Physiology12% of their works
- 4Neurology9% of their works
- 5Cellular and Molecular Neuroscience9% of their works
- 6Cell Biology6% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Alzheimer's disease research and treatments
- Prion Diseases and Protein Misfolding
- Neurological diseases and metabolism
- Neurological disorders and treatments
- Genetic Neurodegenerative Diseases
- Nerve injury and regeneration
- Neuroinflammation and Neurodegeneration Mechanisms
Which keywords describe Ronald Melki's research?
The keywords of their largest research topics: Neurodegeneration, Oxidative Stress, Mitochondrial Dysfunction, Parkinson's Disease, a-Synuclein, Dopaminergic Neurons, Neuroinflammation and Protein Aggregation.
- Neurotrophins
- BDNF
- Polyglutamine
- Subthalamic Nucleus
- Pantothenate Kinase
- Prion Diseases
- Tau Pathology
- Protein Aggregation
- a-Synuclein
- Parkinson's Disease
- Oxidative Stress
- Neurodegeneration
- Mitochondrial Dysfunction
- Dopaminergic Neurons
- Neuroinflammation
- Amyloid Hypothesis
- Molecular Basis
- Brain Iron Accumulation
- Deep Brain Stimulation
- Huntington's Disease
- Astrocytes
- Microglia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Neurodegeneration2774 topics
- Oxidative Stress2082 topics
- Mitochondrial Dysfunction1943 topics
- Parkinson's Disease1582 topics
- Dopaminergic Neurons1221 topic
- a-Synuclein1221 topic
- Neuroinflammation1072 topics
- Protein Aggregation942 topics
- Amyloid Hypothesis861 topic
- Tau Pathology861 topic
- Molecular Basis701 topic
- Prion Diseases701 topic
- Brain Iron Accumulation481 topic
- Pantothenate Kinase481 topic
- Deep Brain Stimulation361 topic
- Subthalamic Nucleus361 topic
- Huntington's Disease241 topic
- Polyglutamine241 topic
- Astrocytes211 topic
- BDNF211 topic
- Microglia211 topic
- Neurotrophins211 topic
Where does Ronald Melki work?
Ronald Melki's main affiliation in the publication record is Centre National de la Recherche Scientifique, France.
How many publications and citations does Ronald Melki have?
OpenAlex counts 289 works and 21,196 citations for Ronald Melki, an h-index of 74, ranking #52,926 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ronald Melki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.